Cerebral Venous Thrombosis at High Altitude: A Retrospective Cohort of Twenty-one Consecutive Patients.
cerebral venous thrombosis
developing countries
gos
low-molecular-weight heparin
patient management
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
19 Jun 2019
19 Jun 2019
Historique:
entrez:
22
8
2019
pubmed:
23
8
2019
medline:
23
8
2019
Statut:
epublish
Résumé
Background Cerebral venous thrombosis (CVT) is a rare cerebrovascular disorder, comprising <1% of all strokes. The incidence of CVT is higher in females but a small number of cases suggest that men have a higher risk for CVT in high elevation. The aim of this retrospective cohort study is to investigate this gender-related relationship and to describe the baseline characteristics and treatment outcomes of patients who suffered CVT at high altitude in eastern Nepal. Methods We conducted a retrospective analysis of 21 consecutive patients with CVT at a tertiary care center in Nepal from July 2017 to January 2018. Clinical data, radiologic characteristics, therapeutic strategies, and outcomes were analyzed. The Glasgow Outcome Scale (GOS) at discharge was reported for each patient. Result The study cohort comprised 21 patients (76% males) with a mean of 56 years. Medical comorbidities included hypertension (76%) and diabetes mellitus (57%). All patients received low-molecular-weight heparin therapy (LMWH). Eight patients (38%) underwent decompressive craniectomy while the remaining 13 (62%) were treated with medical therapy alone. The GOS at discharge was 5 in 57%, 2-4 in 33%, and 1 in 10%. Conclusion In our series, men were found to have a higher risk for CVT at high altitude. The reversal in the gender ratio could be related to elevation, but could also be confounded by alcoholism. Increasingly sophisticated imaging techniques, such as computed tomography venography (CTV) and magnetic resonance venography (MRV), have facilitated the diagnosis of CVT. LMWH is a safe and easily accessible treatment option, especially in developing countries. Further studies are needed to assess the incidence and prevalence of CVT in the developing world, to establish the gender-related trends.
Identifiants
pubmed: 31431845
doi: 10.7759/cureus.4940
pmc: PMC6697453
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e4940Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Cerebrovasc Dis. 2001;11(3):177-82
pubmed: 11306764
Stroke. 2004 Mar;35(3):664-70
pubmed: 14976332
High Alt Med Biol. 2004 Summer;5(2):171-9
pubmed: 15265338
J Pak Med Assoc. 2006 Nov;56(11):501-6
pubmed: 17183976
Stroke. 2009 Jul;40(7):2356-61
pubmed: 19478226
Cerebrovasc Dis. 2010;30(4):418-22
pubmed: 20720411
Eur J Neurol. 2012 Jul;19(7):1030-6
pubmed: 22416902
Semin Thromb Hemost. 2013 Nov;39(8):913-27
pubmed: 24129682
J Clin Neurol. 2013 Oct;9(4):259-68
pubmed: 24285968
Acta Neurochir (Wien). 2014 May;156(5):999-1007; discussion 1007
pubmed: 24573982
Curr Cardiol Rep. 2014 Sep;16(9):523
pubmed: 25073867
Stroke. 2015 Jan;46(1):245-7
pubmed: 25378420
J Neurol. 2015;262(4):931-7
pubmed: 25663408
Stroke. 2015 May;46(5):1263-8
pubmed: 25899238
J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1679-84
pubmed: 25934140
J Thromb Haemost. 2015 Jun;13 Suppl 1:S238-44
pubmed: 26149030
Case Rep Neurol Med. 2016;2016:8314040
pubmed: 27872776
J Neurointerv Surg. 2017 Nov;9(11):1086-1092
pubmed: 28213478
Rev Neurol (Paris). 2017 Jun;173(6):411-417
pubmed: 28495232
Nat Rev Neurol. 2017 Sep;13(9):555-565
pubmed: 28820187
Eur J Neurol. 2017 Oct;24(10):1203-1213
pubmed: 28833980
Neurosurg Clin N Am. 2018 Oct;29(4):585-594
pubmed: 30223971
Int J Surg. 2018 Dec;60:279-282
pubmed: 30359781
Lancet. 1976 May 15;1(7968):1031-4
pubmed: 57446
Clin Radiol. 1997 Sep;52(9):672-9
pubmed: 9313731